Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co LtdfiledCriticalFujisawa Pharmaceutical Co Ltd
Priority to JP36376ApriorityCriticalpatent/JPS5283784A/ja
Priority to BE164026Aprioritypatent/BE838190A/fr
Publication of JPS5283784ApublicationCriticalpatent/JPS5283784A/ja
Publication of JPS6145629B2publicationCriticalpatent/JPS6145629B2/ja
Syn-isomer of 3,7-disubstd.-3-cephem-4-carboxylic acids, and their preventingor treating agents containing their salts as active constituent againstdiseases caused by bacterial infection
3,7-disubstituted-2 or 3-cephem-4-carboxylic acid compound or its salt, their preparation, and preventives and remedies for microbism comprising them as active constituents
Nya 2-aminotiazolderivat eller salter derav for framstellning av 2-(2-aminotiazol-4-yl)-glyoxylsyraderivat eller ett salt derav samt forfarande for framstellning av dessa
7-substituted ureido-3-cephem-4-carboxylic acid derivative, its preparation and preventing agent and remedy for microbism containing the same as active constituent